✦ LIBER ✦

Dabigatran, Rivaroxaban and Apixaban versus Enoxaparin for thomboprophylaxis after total knee or hip arthroplasty: Pool-analysis of phase III randomized clinical trials

✍ Scribed by José A. Nieto; Noelia Garrido Espada; Ricardo Guijarro Merino; Timoteo Cámara González

Book ID: 116915012
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 568 KB
Volume: 130
Category: Article
ISSN: 0049-3848
DOI: 10.1016/j.thromres.2012.02.011

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rivaroxaban versus enoxaparin for thromb

Rivaroxaban versus enoxaparin for thromboprophylaxis after total hip or knee arthroplasty: a meta-analysis of randomized controlled trials

✍ Yong Bing Cao; Jun Dong Zhang; Hui Shen; Yuan Ying Jiang 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 659 KB

Dabigatran versus enoxaparin for prevent

Dabigatran versus enoxaparin for prevention of venous thromboembolism after hip or knee arthroplasty: A pooled analysis of three trials

✍ R.J. Friedman; O.E. Dahl; N. Rosencher; J.A. Caprini; A.A. Kurth; C.W. Francis; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 664 KB

Apixaban versus enoxaparin for thrombopr

Apixaban versus enoxaparin for thromboprophylaxis after hip or knee replacement: pooled analysis of major venous thromboembolism and bleeding in 8464 patients from the ADVANCE-2 and ADVANCE-3 trials

✍ Raskob, G. E.; Gallus, A. S.; Pineo, G. F.; Chen, D.; Ramirez, L.-M.; Wright, R. 📂 Article 📅 2012 🏛 British Editorial Society of Bone & Joint Surgery 🌐 English ⚖ 332 KB